
Delcath Systems DCTH
$ 9.26
1.48%
Quarterly report 2025-Q3
added 11-04-2025
Country |
|
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
28.5 M |
Market Cap[1] |
$ 264 M |
EBITDA (LTM) |
$ 1.93 M |
P/E (LTM) |
48.16 |
P/S (LTM) |
3.45 |
EPS (LTM) |
0.19 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AxoGen
AXGN
|
$ 33.23 | 1.9 % | $ 1.47 B | Nasdaq Capital Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 7.08 | 2.98 % | $ 508 M | Nasdaq Global Select Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.75 | -1.83 % | $ 130 M | Nasdaq Global Select Market | ||
|
Alphatec Holdings
ATEC
|
$ 13.37 | 2.06 % | $ 1.91 B | Nasdaq Global Select Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 4.7 | -1.44 % | $ 175 M | Nasdaq Global Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 24.35 | 4.46 % | $ 206 M | NYSE American | ||
|
Bio-Rad Laboratories
BIO
|
$ 253.63 | -13.27 % | $ 7.16 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Bruker Corporation
BRKR
|
$ 36.37 | -3.05 % | $ 5.42 K | Nasdaq Global Select Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 41.78 | 0.26 % | $ 1.29 B | NYSE,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 74.89 | 1.04 % | $ 110 B | NYSE,SPB | ||
|
Abbott Laboratories
ABT
|
$ 112.43 | 0.86 % | $ 196 B | NYSE,SPB | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 13.4 | 2.76 % | $ 362 M | Nasdaq Capital Market | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Inogen
INGN
|
$ 5.8 | 0.17 % | $ 137 M | Nasdaq Global Select Market,SPB | ||
|
InMode Ltd.
INMD
|
$ 14.41 | 0.79 % | $ 1.14 B | Nasdaq Global Select Market,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 100.64 | 0.8 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.49 | 4.58 % | $ 58.3 M | Nasdaq Global Select Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.98 | 0.73 % | $ 2.89 B | NYSE,SPB | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Penumbra
PEN
|
$ 340.06 | 0.4 % | $ 13.1 B | NYSE,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 18.55 | 0.03 % | $ 122 M | Nasdaq Capital Market | ||
|
Insulet Corporation
PODD
|
$ 244.13 | 1.37 % | $ 17.1 B | Nasdaq Global Select Market,SPB | ||
|
Profound Medical Corp.
PROF
|
$ 6.56 | 5.3 % | $ 180 M | Nasdaq Global Select Market | ||
|
Globus Medical
GMED
|
$ 88.42 | 1.38 % | $ 12 B | NYSE,SPB | ||
|
Sintx Technologies
SINT
|
$ 3.0 | 10.29 % | $ 11.2 M | Nasdaq Capital Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.